Published in Am J Physiol on May 01, 1976
Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest (1979) 1.42
Hepatic ethanol elimination kinetics in patients with cirrhosis. Scand J Gastroenterol (2009) 1.41
Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography. Am J Physiol Gastrointest Liver Physiol (2008) 1.22
Nucleophilic radiosynthesis of 2-[18F]fluoro-2-deoxy-D-galactose from Talose triflate and biodistribution in a porcine model. Nucl Med Biol (2011) 1.00
Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT. J Nucl Med (2011) 0.98
Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT. J Hepatol (2013) 0.87
Transport of D-fructose and D-galactose into isolated rat hepatocytes. Biochem J (1980) 0.78
Familial and nonfamilial benign recurrent cholestiasis distinguished by plasma disappearance of indocyanine green but not cholylglycine. Gut (1978) 0.78
Bringing physiology into PET of the liver. J Nucl Med (2012) 0.77
Analogue tracers and lumped constant in capillary beds. J Theor Biol (2011) 0.76
Long-term and short-term effects of hemodialysis on liver function evaluated using the galactose single-point test. ScientificWorldJournal (2014) 0.75
Orotate decreases the inhibitory effect of ethanol on galactose elimination in the perfused rat liver. Biochem J (1976) 0.75
Age-dependency of galactose elimination capacity in healthy children and children with chronic liver disease. Scand J Gastroenterol (2010) 0.75
The framing effect of relative and absolute risk. J Gen Intern Med (1993) 4.87
Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation. Bone Marrow Transplant (1999) 2.53
Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem (1998) 2.44
Relapse of MALT lymphoma associated with Helicobacter pylori after antibiotic treatment. Lancet (1994) 2.42
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J (1999) 2.29
Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging (1994) 2.27
Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol (1996) 2.13
Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer (1988) 2.11
Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain (2000) 2.04
Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl (1966) 2.03
Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology (1984) 1.95
Malignant peripheral neuroectodermal tumors. A retrospective analysis of 42 patients. Cancer (1988) 1.92
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol (1998) 1.79
Metabolites of (18)F-FDG and 3-O-(11)C-methylglucose in pig liver. J Nucl Med (2001) 1.59
Studies of the RB1 gene and the p53 gene in human osteosarcomas. Pediatr Hematol Oncol (1992) 1.57
Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol (1986) 1.57
Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol (1999) 1.45
Chronic consumption coagulopathy due to an occult splenic haemangioma: Kasabach-Merritt syndrome. Eur J Pediatr (1995) 1.44
Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem (1998) 1.41
A simple method for determination of antipyrine clearance. Clin Pharmacol Ther (1982) 1.41
Surgical excision of the sinus node in a patient with inappropriate sinus tachycardia. J Thorac Cardiovasc Surg (1997) 1.38
Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell (1997) 1.35
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology (1980) 1.33
Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis (1986) 1.29
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology (1981) 1.25
Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation (1986) 1.24
The Lugano statements on controlled clinical trials. J Int Med Res (1987) 1.23
Methotrexate pharmacokinetics and prognosis in osteosarcoma. J Clin Oncol (1994) 1.22
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol (1998) 1.20
Nucleotide sequence of the Physarum polycephalum small subunit ribosomal RNA as inferred from the gene sequence: secondary structure and evolutionary implications. Curr Genet (1988) 1.20
Clearance of antipyrine-dependence of quantitative liver function. Eur J Clin Invest (1974) 1.19
Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci (1998) 1.19
[Antiandrogens in dermatology. (Gravimetric fatdeterminations during the application of cyproterone)]. Arch Klin Exp Dermatol (1968) 1.19
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. J Clin Oncol (1984) 1.19
Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet (1977) 1.18
Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol (1998) 1.16
Multiplex PCR for rapid detection of T-cell receptor-gamma chain gene rearrangements in patients with lymphoproliferative diseases. Br J Haematol (1996) 1.15
Peripheral ligation of the hepatic artery during surgery in non-cirrhotic patients. Gut (1962) 1.15
Symptom-giving pelvic girdle relaxation in pregnancy. I: Prevalence and risk factors. Acta Obstet Gynecol Scand (1999) 1.14
Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol (1999) 1.13
Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut (1976) 1.13
A new nomenclature of group I introns in ribosomal DNA. RNA (2001) 1.12
Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature. Graefes Arch Clin Exp Ophthalmol (1994) 1.12
Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. J Nucl Med (2001) 1.11
Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver (1987) 1.10
Two group I ribozymes with different functions in a nuclear rDNA intron. EMBO J (1995) 1.10
Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand (1969) 1.10
Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology (1983) 1.06
Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol (1976) 1.06
Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology (1980) 1.06
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol (1999) 1.06
In vivo expression of the nucleolar group I intron-encoded I-dirI homing endonuclease involves the removal of a spliceosomal intron. EMBO J (1999) 1.05
Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups. Gastroenterology (1993) 1.03
Group I-like ribozymes with a novel core organization perform obligate sequential hydrolytic cleavages at two processing sites. RNA (1998) 1.03
Glycerol metabolism in the human liver: inhibition by ethanol. Science (1965) 1.03
Symptom-giving pelvic girdle relaxation in pregnancy. II: Symptoms and clinical signs. Acta Obstet Gynecol Scand (1999) 1.02
Rapid disappearance of one parental mitochondrial genotype after isogamous mating in the myxomycete Physarum polycephalum. Curr Genet (1991) 1.01
Osteosarcoma of the trunk treated by multimodal therapy: experience of the Cooperative Osteosarcoma study group (COSS). Med Pediatr Oncol (1995) 1.01
Characterization of the self-splicing products of a mobile intron from the nuclear rDNA of Physarum polycephalum. Nucleic Acids Res (1992) 1.00
Naegleria nucleolar introns contain two group I ribozymes with different functions in RNA splicing and processing. RNA (1997) 1.00
Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study). J Thromb Haemost (2008) 0.99
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut (1985) 0.98
Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer (1992) 0.98
Glucose homeostasis during exercise in humans with a liver or kidney transplant. Am J Physiol (1995) 0.98
Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol (1987) 0.97
Ultrasonography, computed tomography, and cholescintigraphy in suspected obstructive jaundice--a prospective comparative study. Gastroenterology (1983) 0.97
High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs (1992) 0.97
Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes Chromosomes Cancer (1999) 0.97
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia (2004) 0.96
Protein synthesis in human leucocytes. IV. Mutual inhibition of amino acid incorporation by amino acids in cell suspensions and cell-free systems. Hoppe Seylers Z Physiol Chem (1972) 0.96
Behaviour of single wood fibres under axial tensile strain. Nature (1971) 0.96
Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients. Atherosclerosis (2010) 0.96
Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin). Pharmacol Toxicol (2001) 0.96
Group I twintrons: genetic elements in myxomycete and schizopyrenid amoeboflagellate ribosomal DNAs. J Biotechnol (1998) 0.96
Hepatic galactose elimination kinetics in the intact pig. Scand J Clin Lab Invest (1982) 0.96
Flow cytometric detection of mitochondrial dysfunction in subpopulations of human mononuclear cells. Anal Biochem (1997) 0.96
Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterol (1975) 0.96
Measurement of fluorescence changes of NAD(P)H and of fluorescent flavoproteins in saponin-skinned human skeletal muscle fibers. Anal Biochem (1994) 0.95
Effect of sites of blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest (1977) 0.95
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose. Acta Oncol (2000) 0.94
PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer. Br J Cancer (2011) 0.94
Protein synthesis in human leucocytes. 3. Kinetics of the flow of amino acids from the extracellular space and the intracellular pools resulting in protein synthesis. Hoppe Seylers Z Physiol Chem (1972) 0.93
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis. Am J Clin Pathol (1999) 0.93
Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood (1994) 0.93
Fulminant hepatic failure. Clin Gastroenterol (1981) 0.93
Pharmacokinetic investigation of fusidic acid 1% viscous eye drops in healthy volunteers. Eur J Ophthalmol (1997) 0.92
Female fertility loss and preservation: threats and opportunities. Ann Oncol (2012) 0.92
Autoprotection in acetaminophen intoxication in rats: the role of liver regeneration. Pharmacol Toxicol (2001) 0.92
Unfolding and refolding of phospholipase C from Bacillus cereus in solutions of guanidinium chloride. Biochem J (1979) 0.91
Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci (1999) 0.91
Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem (1995) 0.91